Phase 3b, Multicenter, Randomized, Double-Blind, Parallel-Group Study Evaluating Efficacy and Safety of Investigational Oral Edaravone Administered over 48 Weeks in Patients with Amyotrophic Lateral Sclerosis

ANNALS OF NEUROLOGY(2022)

引用 0|浏览3
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要